News

Nortech Systems said that the Milaca operation specialises in design, manufacturing and post-production services of complex electronic and electromechanical medical devices for diagnostic, analytical and other life-science applications.

Aurobindo Pharma claimed that with these approvals the company now has 11 products approved by Health Canada. Cefprozil is a second-generation cephalosporin type antibiotic. In Europe, it is

The Intrepid2566 trial is expected to seek to enroll a total of 260 patients with moderate to severe brain injury. Patients will be randomised 2:1 for drug and

BioInvent International and ThromboGenics said that the Phase II results demonstrate that TB-402 has superior antithrombotic activity to enoxaparin with comparable safety. Enoxaparin is currently the standard treatment

Synairgen said that the issued patent is part of a patent portfolio owned by the University of Southampton, which is exclusively licensed to Synairgen. Reportedly, laboratory experiments were

SIPO said that as a high growth company with a focus on technology innovation and intellectual property, Renhuang was selected as one of a handful pharmaceutical companies from

As per the restructured agreement, Merck has acquired full control of the development and worldwide commercialisation of Ridaforolimus. Ariad is expected to receive a $50m upfront fee and

The poster is presented at ‘The Power of Programming 2010 International conference on developmental origins of health and disease’ in Munich, Germany. Swedish Orphan Biovitrum claimed that Kiobrina

The study demonstrated that single intravenous doses of 1 and 3mcg of CTAP201 were safe and well tolerated. It also identified a starting dose of 2mcg for subsequent